In the proposed breast cancer gene group, mutations in BARD1 were found significantly more frequently in individuals with FBC than in ExAC controls (OR = 3.18, 95% CI 1.34–7.36, p = 0.012) (Table 3). The gene discussed is BARD1; the disease is breast carcinoma.